Higher CD27⁺CD8⁺ T Cells Percentages during Suppressive Antiretroviral Therapy Predict Greater Subsequent CD4⁺ T Cell Recovery in Treated HIV Infection

• Lillian Seu,

  Affiliations Department of Bioengineering and Therapeutic Sciences, Department of Pharmacy, University of California San Francisco, San Francisco, California, United States of America, Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Gabriel M. Ortiz,

  Affiliations Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Division of Infectious Diseases, Department of Medicine, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Lorrie Epling,

  Affiliations Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Core Immunology Laboratory, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Elizabeth Sinclair,

  Affiliations Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Core Immunology Laboratory, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Louise A. Swainson,

  Affiliation Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Urmila D. Bajpai,

  Affiliations Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Division of Rheumatology, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Yong Huang,

  Affiliation Department of Bioengineering and Therapeutic Sciences, Department of Pharmacy, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Steven G. Deeks,

  Affiliation Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Peter W. Hunt,

  Affiliation Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Jeffrey N. Martin,

  Affiliations Positive Health Program, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America, Department of Epidemiology and Biostatistics, University of California San Francisco, San Francisco, California, United States of America

  ⨯
• Joseph M. McCune

  * E-mail: mike.mccune@ucsf.edu

  Affiliation Division of Experimental Medicine, Department of Medicine, San Francisco General Hospital, University of California San Francisco, San Francisco, California, United States of America

  ⨯